Ocugen (OCGN) Change in Acquisitions & Divestments (2017 - 2023)
Ocugen's (OCGN) quarterly Change in Acquisitions & Divestments came in at $8.5 million in Q2 2023, down 5.56% on a QoQ basis from $9.0 million in Q1 2023.
Powered by 
Analysis
Ocugen (OCGN) Change in Acquisitions & Divestments (2017 - 2023) Analysis & Trends
Ocugen (OCGN) has 3 years of Change in Acquisitions & Divestments data on file, last reported at $8.5 million in Q2 2023.
- Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $8.5 million in Q2 2023, while the trailing twelve-month figure through Mar 2024 was $8.5 million (down 5.56% YoY) and the FY2023 annual result came in at $17.5 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments retreated to $8.5 million in Q2 2023, from $9.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $9.0 million in Q1 2023 to a low of $8.5 million in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Ocugen | 458.91 Mn | 358.81 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 8.50 Mn |
| Mar 31, 2023 | 9.00 Mn |
| Mar 31, 2018 | 900,000.00 |
| Dec 31, 2017 | 891,000.00 |